View Older Stories View More Recent Stories

Feb 10, 2025 09:00AM Form SCHEDULE 13G/A Protagonist Therapeutics Filed by: Farallon Capital Partners, L.P.
Feb 5, 2025 07:31PM Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
Feb 5, 2025 05:24PM Form SCHEDULE 13G/A NEW YORK TIMES CO Filed by: Farallon Capital Partners, L.P.
Feb 5, 2025 04:28PM Form SCHEDULE 13G/A Elevation Oncology, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 5, 2025 01:10PM Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 4, 2025 12:02PM Form SCHEDULE 13G/A AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
Feb 3, 2025 10:59PM KKR sweetens offer for Fuji Soft as bidding war with Bain goes another round
Feb 3, 2025 06:31AM Tectonic Therapeutic (TECX) Announces $185M Private Placement
Feb 3, 2025 06:30AM Tectonic Announces $185 Million Private Placement
Dec 19, 2024 04:01AM KKR extends tender offer period for Japan's Fuji Soft to Jan 9
Dec 17, 2024 07:43PM Bain and KKR battle for Fuji Soft heats up as Bain goes hostile
Dec 17, 2024 08:32AM Fuji Soft rejects Bain's raised buyout offer and sticks with KKR
Nov 26, 2024 01:08PM Nasdaq Private Market Announces 2024 Executive Leadership Team Promotions
Nov 26, 2024 05:23AM Explainer-What's behind the private equity battle for Fuji Soft?
Nov 14, 2024 08:22PM Form SC 13G Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
Nov 14, 2024 10:21AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Nov 14, 2024 09:25AM Form 13F-NT Farallon Capital Europe For: Sep 30
Nov 14, 2024 09:24AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Sep 30
Nov 8, 2024 05:15PM Form SC 13G/A Longboard Pharmaceutical Filed by: Farallon Capital Partners, L.P.
Nov 8, 2024 02:58PM Form SC 13G/A Aramark Filed by: Farallon Capital Partners, L.P.
Nov 8, 2024 02:41PM Form SC 13G/A AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
Nov 8, 2024 11:56AM Form SC 13G/A Elevation Oncology, Inc. Filed by: Farallon Capital Partners, L.P.
Nov 7, 2024 09:56AM Form SC 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
Nov 6, 2024 08:20PM NexPoint Raises Concerns About UDF IV Board Allowing Millions in Management Fees to Enrich Former UDF Executives Imprisoned for Fraud
Nov 6, 2024 06:34PM Form SC 13G/A Savara Inc Filed by: Farallon Capital Partners, L.P.
Nov 6, 2024 05:06PM Form SC 13G/A Swiftmerge Acquisition Filed by: Farallon Capital Partners, L.P.
Nov 5, 2024 10:56PM KKR acquires 35% of Fuji Soft after first stage of tender offer
Oct 21, 2024 07:27PM Fuji Soft's top shareholder confirms support for KKR takeover bid
Oct 21, 2024 04:03AM KKR extends tender period for Fuji Soft to November
Oct 18, 2024 05:03AM Fuji Soft board backs first stage of KKR's buyout offer
Oct 17, 2024 09:33AM Fuji Soft founder backs buyout by Bain over KKR offer, letter says
Oct 16, 2024 04:36PM Form SC 13D Squarespace, Inc. Filed by: Farallon Capital Partners, L.P.
Sep 4, 2024 08:00AM eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant
Sep 3, 2024 08:41AM Form N-PX FARALLON CAPITAL MANAGEM For: Jun 30
Aug 22, 2024 12:44PM Newmark Secures $985 Million Financing on Behalf of 80 Clarkson Developers in New York City
Aug 14, 2024 01:32PM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Aug 14, 2024 01:31PM Form 13F-NT Farallon Capital Europe For: Jun 30
Aug 14, 2024 01:30PM Form 13F-HR FARALLON CAPITAL MANAGEM For: Jun 30
Aug 14, 2024 06:14AM Anaptysbio (ANAB) Prices 2.75M Share Offering at $36.50/sh
Aug 14, 2024 05:00AM Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
Jul 16, 2024 09:00AM Cardurion Pharmaceuticals Announces $260 Million Series B Financing to Advance Its Pipeline of Innovative Medicines for Cardiovascular Diseases
Jul 8, 2024 07:34AM CASI Pharmaceuticals (CASI) announces appointment of Daniel Lang, MD as CFO and SVP
Jul 8, 2024 07:30AM CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP
Jul 3, 2024 09:12AM Form D/A Farallon Capital F5 Inve
Jul 3, 2024 09:07AM Form D/A Farallon Capital F5 Inve
Jun 28, 2024 08:50AM Savara (SVRA) Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
Jun 28, 2024 08:50AM Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
Jun 20, 2024 04:01PM Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million
May 24, 2024 03:06PM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
May 17, 2024 04:59PM Form SC 13G NanoString Technologies Filed by: Farallon Capital Partners, L.P.
View More Recent Stories View Older Stories